PMR Ltd, March 2011, Pages: 161
and immunomodulating agents
- Sensory organs
- Systemic hormonal preparations
- Parasitology
V. Best selling drugs
VI. Pharmaceutical companies in Poland
VII. Pricing
- Principles
- Process
- Generic pricing
PMR Ltd, March 2011, Pages: 161
and immunomodulating agents
- Sensory organs
- Systemic hormonal preparations
- Parasitology
V. Best selling drugs
VI. Pharmaceutical companies in Poland
VII. Pricing
- Principles
- Process
- Generic pricing
Biopharm Knowledge Publishing, Nov 2009 Activation Plan
1.5 Comparison of Review Time for Japan and US
1.6 Avg. Time Taken to Launch Foreign Origin New Drugs
1.7 Approval Process for Generic Drugs
1.8 Drug Pricing Process for New Drugs
2.1 Relations
Business Monitor International, Dec 2010, Pages: 92
or delaying their payments to wholesalers. Executive Summary
SWOT Analysis
Serbia Pharmaceuticals And Healthcare Industry SWOT
Serbia Political SWOT
Serbia Economic SWOT
Serbia Business Environment SWOT
Butler Group, July 2009, Pages: 172
of IT and enterprise applications to improve the business.
With the world economy scaling down, 2009 may not be the time for wholesale new investment, but strategic spending is advisable to maintain the value
Business Monitor International, Dec 2010, Pages: 92
or delaying their payments to wholesalers. Executive Summary
SWOT Analysis
Serbia Pharmaceuticals And Healthcare Industry SWOT
Serbia Political SWOT
Serbia Economic SWOT
Serbia Business Environment SWOT
Business Monitor International, Dec 2010, Pages: 92
or delaying their payments to wholesalers. Executive Summary
SWOT Analysis
Serbia Pharmaceuticals And Healthcare Industry SWOT
Serbia Political SWOT
Serbia Economic SWOT
Serbia Business Environment SWOT
Business Monitor International, Dec 2010, Pages: 92
or delaying their payments to wholesalers. Executive Summary
SWOT Analysis
Serbia Pharmaceuticals And Healthcare Industry SWOT
Serbia Political SWOT
Serbia Economic SWOT
Serbia Business Environment SWOT
Business Monitor International, Dec 2010, Pages: 92
or delaying their payments to wholesalers. Executive Summary
SWOT Analysis
Serbia Pharmaceuticals And Healthcare Industry SWOT
Serbia Political SWOT
Serbia Economic SWOT
Serbia Business Environment SWOT
Business Monitor International, Dec 2010, Pages: 92
or delaying their payments to wholesalers. Executive Summary
SWOT Analysis
Serbia Pharmaceuticals And Healthcare Industry SWOT
Serbia Political SWOT
Serbia Economic SWOT
Serbia Business Environment SWOT
EDM Publications, March 2010, Pages: 1584
, the research is structured in the same way as the publisher's previous reports and reviews 120 different topics including:
- Trends in sports participation and governmental initiatives to promote sports activities
- Import
Business Monitor International, June 2009, Pages: 94
by the lag from an AUD10.4bn (US$7.2bn) fiscal stimulus measure, in the form of cash handouts, distributed in December. The second round of cash payments, AUD12.3bn (US$8.5bn) – distributed in mid-March
Paul Budde Communication Pty Ltd., Dec 2011, Pages: 71
to promote m-payment services;
- T-Mobile extends HSPA+ coverage to most of the population;
- Telefónica and T-Mobile sign six-year 3G network sharing agreement;
- mobile market revenue grew 1.9% in 2010
Business Monitor International, Dec 2007, Pages: 65
for this is the year-on-year fall in spending in the DLO reimbursement programme following major cuts in Q407 and significant arrears still owed to distributors. RMBC’s pharmacy market figures for H107 showed 24% y-o-y
EDM Publications, Sep 2008, Pages: 1832
context – Sports participation – Production and trade in sporting goods – Market size and growth – Analysis of 10 major sports categories – The supply chain at the wholesale and retail levels - Consumers
Business Monitor International, April 2009, Pages: 83
in emerging retail markets – are not yet present in India, except in the wholesale sector, although their arrival is imminent. This delay in multinational entry has provided local operators with a window
Business Monitor International, Aug 2011, Pages: 109
, Approvals Process and Policy/Reimbursement.
Key Trends & Developments
- In July 2011, Teva Pharmaceutical Industries acquired 100% of the outstanding shares of Japan's Taiyo Pharmaceutical Industry for US
Business Monitor International, April 2009, Pages: 73
sales in Poland suggest that the market holds significant potential for drug makers. Healthy levels of growth, coupled with an already substantial market size, saw per capita spending rise to US$215
EDM Publications, March 2010, Pages: 387
This report looks at the trends in sports participation and governmental initiatives to promote sports activities. It also provides import-export statistics from the last few years
The report
Business Monitor International, Aug 2009, Pages: 92
, with estimates suggesting that counterfeits represent 10% of the market.
Other challenges facing companies active in – or those considering entry into – the Turkish pharmaceutical market include the possible
